Century-old Vaccine Protects Type 1 Diabetics from Infectious Diseases
BCG-treated individuals had a significantly lower rate of COVID-19 infection compared with the placebo group and a significantly lower rate of infectious diseases overall.
Endocrinology
Contact Information
50 Staniford Street, Third Floor, Suite 340
Boston,
MA
2114
Hours:
Weekdays, 8:30 am–5:00 pm,
Closed 12:00 – 1:00 pm
After hours: Call 617-726-2000 for the diabetes MD on call
Your primary care physician is responsible for arranging all of your medical care, including referrals to specialists. If you think you need to see a specialist, please call us at 617-726-8722.
We accept most major insurance and managed care plans. Please confirm that we accept your plan before your first visit or when you change carriers. If you are required to choose a primary care physician, please make sure to name a Mass General Diabetes/Internist doctor.
Your physician will send most laboratory results directly to you. In case of an urgent result, a physician will call you as soon as possible. If you have any questions about your results, please call 617-726-8722. If you would like to sign up for Patient Gateway to access your results over the internet, please see someone at the front desk on your next visit.
To refill a prescription during center hours, call us at 617-726-8722.
Please have on hand your:
Please allow 48 hours to process your prescription.
The Pediatric Endocrinology Unit at Mass General for Children provides care for children and adolescents with diabetes.
With a closely integrated treatment center and clinical research center, we aim to develop new treatments and provide the highest quality care for people with diabetes, pre-diabetes, and associated disorders. The ultimate goal of our work is to cure diabetes. However, until cures are developed, we offer the most advanced comprehensive therapy available for Type 1 and Type 2 diabetes and for the complications associated with diabetes. We also offer evaluation of rarer forms of diabetes including monogenic diabetes and Maturity Onset Diabetes of the Young (MODY).
The Diabetes Clinical Center currently handles approximately 10,000 patient visits per year. The usual age range for our patients begins at age 18; the Pediatric Endocrinology Unit and Diabetes Center at Mass General for Children provides care for children and adolescents with diabetes. In addition to treating the metabolic abnormalities of approximately 2500 adults with type 1 and type 2 diabetes, the staff focuses on prevention of complications and rapid, effective treatment of those complications should they occur. The associated medical problems of obesity, pre-diabetes and metabolic syndrome, dyslipidemia, hypertension, eye, kidney, nerve, and cardiovascular disease are all addressed by the clinical staff.
In collaboration with other Mass General experts in renal disease, cardiology, podiatry and orthopedics, neurology, and vascular surgery, and retinal specialists and other ophthalmologists from the Mass Eye and Ear Infirmary and other specialty ophthalmology groups, comprehensive medical care is provided to all of our patients. The Diabetes Clinical Center staff includes 15 physicians, all of whom are Harvard Faculty, fellows who are training in endocrinology, diabetes and metabolism, highly experienced diabetes nurse practitioners, nurse certified diabetes educators and dietitians, physician assistants, and a highly committed and experienced support staff.
The center provides consultation about methods of glucose monitoring, injections and medication. On-site services include:
Many of the modern-day therapies have been developed at the Mass General Diabetes Clinical Research Center. Patients who attend the Diabetes Clinical Center often participate in research studies. When new therapies are developed, tested, and proved to be beneficial, the Mass General Diabetes Center patients are often the first to benefit from their use. The combination of a clinical treatment center and research center sharing space “under one roof” results in a highly effective and efficient setting for clinical research and clinical care.
Melatonin Sleep Study needs healthy Caucasian non-smokers between the ages of 21-55!
U.S. News & World Report ranks Mass General Diabetes & Endocrinology among the best in the nation.
Dr. Powe discusses her work to understand diabetes and pregnancy, as well as how she hopes to develop more personalized treatments for these patients.
For nearly 30 years, the research and clinical management services at Mass General’s Diabetes Unit has revolutionized the treatment of diabetes.
BCG-treated individuals had a significantly lower rate of COVID-19 infection compared with the placebo group and a significantly lower rate of infectious diseases overall.
The findings set the stage for novel approaches to modulate insulin resistance in pregnancy and prevent or treat gestational diabetes mellitus (GDM).
The study was designed to compare four major medications approved by the FDA to treat diabetes in combination with metformin, the usual first-line drug.
Researchers have identified numerous genetic clusters that may help explain why people with type 2 diabetes have different clinical presentations.
Florez now oversees the largest clinical and research department at Mass General, with 10 clinical divisions, seven research centers/units, and 19 training programs comprising over 1,000 faculty members, 900 trainees and 100 medical practices.
Short description of the study goes here. And be sure to update the link below to the new spotlight page you just created.